Innovator IBD 50 ETF (NYSEARCA:FFTY) Trading Up 2.5% – Here’s What Happened

Innovator IBD 50 ETF (NYSEARCA:FFTY) was up 2.5% on Tuesday . The company traded as high as $38.12 and last traded at $38.04. 26,855 shares changed hands during trading, a decline of 58% from the average session volume of 64,038 shares. The stock had previously closed at $37.12.

Innovator IBD 50 ETF Stock Performance

The firm has a market capitalization of $79.51 million, a price-to-earnings ratio of 30.34 and a beta of 1.47. The company has a fifty day moving average of $40.16 and a two-hundred day moving average of $38.51.

Institutional Investors Weigh In On Innovator IBD 50 ETF

A number of hedge funds and other institutional investors have recently modified their holdings of FFTY. AlphaCore Capital LLC bought a new stake in shares of Innovator IBD 50 ETF in the fourth quarter valued at about $32,000. International Assets Investment Management LLC bought a new stake in Innovator IBD 50 ETF in the 4th quarter valued at about $35,000. Advisory Services Network LLC bought a new stake in Innovator IBD 50 ETF in the 3rd quarter valued at about $43,000. Simplex Trading LLC acquired a new position in shares of Innovator IBD 50 ETF during the 4th quarter worth approximately $41,000. Finally, Kestra Advisory Services LLC acquired a new position in shares of Innovator IBD 50 ETF during the 4th quarter worth approximately $72,000.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.